Details for New Drug Application (NDA): 065373
✉ Email this page to a colleague
The generic ingredient in AMOXICILLIN AND CLAVULANATE POTASSIUM is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
Summary for 065373
| Tradename: | AMOXICILLIN AND CLAVULANATE POTASSIUM |
| Applicant: | Hikma Pharms |
| Ingredient: | amoxicillin; clavulanate potassium |
| Patents: | 0 |
Pharmacology for NDA: 065373
| Mechanism of Action | beta Lactamase Inhibitors |
Suppliers and Packaging for NDA: 065373
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065373 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9853 | 0143-9853-16 | 125 mL in 1 BOTTLE (0143-9853-16) |
| AMOXICILLIN AND CLAVULANATE POTASSIUM | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 065373 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9853 | 0143-9853-24 | 200 mL in 1 BOTTLE (0143-9853-24) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 600MG/5ML;EQ 42.9MG BASE/5ML | ||||
| Approval Date: | Nov 9, 2007 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
